| Mrs Amy Lynn Gensler, MA | |
|
6027 Roxbury Ln, Austin, TX 78739-1646 | |
| (512) 636-8227 | |
| Not Available |
| Full Name | Mrs Amy Lynn Gensler |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 24 Years |
| Location | 6027 Roxbury Ln, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821275504 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 51475 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dell Childrens Medical Group | 8224092978 | 91 |
News Archive
A new study from Kaiser Permanente Colorado is one of the first to show that an intensive population management program that matches heart disease patients to personal nurses and clinical pharmacy specialists not only reduces the risk of death but reduces health care costs as well.
Scientists at the National Center for Atmospheric Research (NCAR) and partner organizations from across the country are launching a major field project on the northern Front Range of Colorado this month to track the origins of summertime ozone, an invisible but harmful pollutant.
Chaetocin, a mycotoxin that increases oxidative stress, can complement the activity of tyrosine kinase inhibitors in chronic myeloid leukaemia by overcoming innate resistance mediated by secreted bone marrow stromal cytokines and growth factors, researchers report.
MacroGenics, Inc. and Eli Lilly and Company today announced that the Protege Data Monitoring Committee (DMC), composed of independent experts in the fields of diabetes and biostatistics, has completed a planned analysis of one-year safety and efficacy data of the Protege Phase 3 clinical trial of teplizumab, an investigational biologic under development for the treatment of individuals with recent-onset type 1 diabetes.
A recent study by researchers from Poland, published in the journal Vaccines, shows how levels of IgA and IgG antibodies specific to the spike glycoprotein of SARS-CoV-2 increase in both breast milk and serum samples of mothers following vaccination against COVID-19 – with important implications for further vaccine planning endeavors.
› Verified 9 days ago
| Provider Name | Dell Childrens Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326072943 PECOS PAC ID: 8224092978 Enrollment ID: O20041112001030 |
News Archive
A new study from Kaiser Permanente Colorado is one of the first to show that an intensive population management program that matches heart disease patients to personal nurses and clinical pharmacy specialists not only reduces the risk of death but reduces health care costs as well.
Scientists at the National Center for Atmospheric Research (NCAR) and partner organizations from across the country are launching a major field project on the northern Front Range of Colorado this month to track the origins of summertime ozone, an invisible but harmful pollutant.
Chaetocin, a mycotoxin that increases oxidative stress, can complement the activity of tyrosine kinase inhibitors in chronic myeloid leukaemia by overcoming innate resistance mediated by secreted bone marrow stromal cytokines and growth factors, researchers report.
MacroGenics, Inc. and Eli Lilly and Company today announced that the Protege Data Monitoring Committee (DMC), composed of independent experts in the fields of diabetes and biostatistics, has completed a planned analysis of one-year safety and efficacy data of the Protege Phase 3 clinical trial of teplizumab, an investigational biologic under development for the treatment of individuals with recent-onset type 1 diabetes.
A recent study by researchers from Poland, published in the journal Vaccines, shows how levels of IgA and IgG antibodies specific to the spike glycoprotein of SARS-CoV-2 increase in both breast milk and serum samples of mothers following vaccination against COVID-19 – with important implications for further vaccine planning endeavors.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amy Lynn Gensler, MA 6027 Roxbury Ln, Austin, TX 78739-1646 Ph: (512) 636-8227 | Mrs Amy Lynn Gensler, MA 6027 Roxbury Ln, Austin, TX 78739-1646 Ph: (512) 636-8227 |
News Archive
A new study from Kaiser Permanente Colorado is one of the first to show that an intensive population management program that matches heart disease patients to personal nurses and clinical pharmacy specialists not only reduces the risk of death but reduces health care costs as well.
Scientists at the National Center for Atmospheric Research (NCAR) and partner organizations from across the country are launching a major field project on the northern Front Range of Colorado this month to track the origins of summertime ozone, an invisible but harmful pollutant.
Chaetocin, a mycotoxin that increases oxidative stress, can complement the activity of tyrosine kinase inhibitors in chronic myeloid leukaemia by overcoming innate resistance mediated by secreted bone marrow stromal cytokines and growth factors, researchers report.
MacroGenics, Inc. and Eli Lilly and Company today announced that the Protege Data Monitoring Committee (DMC), composed of independent experts in the fields of diabetes and biostatistics, has completed a planned analysis of one-year safety and efficacy data of the Protege Phase 3 clinical trial of teplizumab, an investigational biologic under development for the treatment of individuals with recent-onset type 1 diabetes.
A recent study by researchers from Poland, published in the journal Vaccines, shows how levels of IgA and IgG antibodies specific to the spike glycoprotein of SARS-CoV-2 increase in both breast milk and serum samples of mothers following vaccination against COVID-19 – with important implications for further vaccine planning endeavors.
› Verified 9 days ago
Dr. William Blunk, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3816 S 1st St, Austin, TX 78704 Phone: 512-443-1311 Fax: 512-406-6266 | |
Bhavana Kancherla, M.A., CCC/A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1208 Tamranae Ct, Austin, TX 78746 Phone: 412-855-9296 | |
Carmen Tyler, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 211 Comal St, Austin, TX 78702 Phone: 512-978-9200 Fax: 512-978-9238 | |
Maribeth Collins, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3705 Medical Pkwy Ste 200, Austin, TX 78705 Phone: 512-324-2720 | |
Dr. Bart Edward Noble, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2901 S. Montopolis Dr., Austin, TX 78741 Phone: 512-389-6505 Fax: 512-389-6559 | |
Rachel C Spinuzza, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3607 Manor Rd Ste 101, Austin, TX 78723 Phone: 512-478-2273 Fax: 512-472-0921 | |
Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3201 Bee Caves Rd Ste 146, Austin, TX 78746 Phone: 512-327-8845 Fax: 512-327-8843 |